Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone

BACKGROUND: Teriparatide (TPTD) should be followed by an antiresorptive to maximize bone mineral density gain and anti-fracture protection. Infrequent zoledronic acid (ZOL) administration has demonstrated effectiveness. The duration of ZOL effect following TPTD is unknown. OBJECTIVE: To evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Giveon, Sharon, Zacay, Galia, Vered, Iris, Foldes, A. Joseph, Tripto-Shkolnik, Liana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666713/
https://www.ncbi.nlm.nih.gov/pubmed/38028331
http://dx.doi.org/10.1177/20420188231213639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666713/
https://www.ncbi.nlm.nih.gov/pubmed/38028331
http://dx.doi.org/10.1177/20420188231213639

Ejemplares similares